ANACOR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Announces the Investigation of Anacor Pharmaceuticals, Inc. (ANAC) Over the P...
May 20 2016 - 2:08PM
Business Wire
Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a
leading national securities firm headquartered in New York City, is
investigating the Board of Directors of Anacor Pharmaceuticals,
Inc. (“Anacor” or the “Company”) (Nasdaq:ANAC) for potential
breaches of fiduciary duties in connection with the sale of the
Company to Pfizer Inc. for approximately $5.2 billion.
The Company’s stockholders will only receive $99.25 in cash for
each share of Anacor common stock they own. However, the offer is
below at least one analyst’s price target of $130 per share and
Anacor’s 52-week high of $156.93 per share.
Click here for more information:
www.faruqilaw.com/ANAC. There is no cost or
obligation to you.
The investigation focuses on whether Anacor’s Board of Directors
breached their fiduciary duties to the Company’s stockholders by
failing to conduct a fair sales process and whether and by how much
this proposed transaction undervalues the Company to the detriment
of Anacor’s shareholders.
Faruqi & Faruqi, LLP is a national law firm which represents
investors and individuals in class action litigation. The firm is
focused on providing exemplary legal services in complex litigation
in the areas of securities, shareholder, antitrust and consumer
litigation, throughout all phases of litigation. The firm has an
experienced trial team which has achieved significant victories on
behalf of the firm’s clients. To keep track of the latest
securities litigation news, follow us on Twitter at
www.twitter.com/MergerActivity or on Facebook at
www.facebook.com/FaruqiLaw.
If you own common stock in Anacor and wish to obtain additional
information and protect your investments free of charge, please
visit us at www.faruqilaw.com/ANAC or contact Juan Monteverde, Esq.
either via e-mail at jmonteverde@faruqilaw.com or by telephone at
(877) 247-4292 or (212) 983-9330.
Attorney Advertising. (C) 2016 Faruqi & Faruqi, LLP. The law
firm responsible for this advertisement is Faruqi & Faruqi, LLP
(www.faruqilaw.com). Prior results do not guarantee or predict a
similar outcome with respect to any future matter. We are happy to
discuss your particular case.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160520005814/en/
Faruqi & Faruqi, LLPJuan Monteverde, Esq.212-983-9330Toll
Free: 877-247-4292jmonteverde@faruqilaw.com
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Anacor Pharmaceuticals, Inc. (NASDAQ:ANAC)
Historical Stock Chart
From Jan 2024 to Jan 2025